HORSHAM, Pa., April 11, 2012 /PRNewswire/ -- Teva Respiratory and the Asthma and Allergy Foundation of America (AAFA) announced today the launch of a national awareness campaign - Ditch

DUBAI, UAE, March 14, 2012 /PRNewswire/ -- - United Arab Emirates is the First Country in the Middle East to Introduce Omnaris(R) to Region's Allergy Sufferers -

LEIDEN, the Netherlands, October 31, 2011 /PRNewswire/ -- HAL Allergy B.V.

GREENWOOD VILLAGE, Colo., Oct. 18, 2011 /PRNewswire/ -- Ampio Pharmaceuticals, Inc.

HORSHAM, Pa., May 10, 2011 /PRNewswire/ -- Teva Respiratory today announced results from the recently completed Nasal Allergy Survey Assessing Limitations (NASL) 2010, which found patients with allergic rhinitis (AR) who had nasal symptoms were more likely to experience sleep disturbances, including difficulty getting to sleep and/or waking up during the night.